Earnings Feed
Start Free
Home/Filings/4/0000893838-06-000053
4//SEC Filing

REXAHN PHARMACEUTICALS, INC. 4

Accession 0000893838-06-000053

$IRDCIK 0001228627operating
View on SEC.govCompany Profile

Filed

May 2, 8:00 PM ET

Accepted

May 3, 9:05 PM ET

Size

12.7 KB

Accession

0000893838-06-000053

Insider Transaction Report

Form 4
Period: 2005-09-12
REXAHN PHARMACEUTICALS, INC.RXHN
Steinfels George F
Chief Business Officer Sr. VP
Transactions
  • Disposition to Issuer

    Stock option (right to buy)

    2005-12-08−250,000→ 0 total
    Exercise: $0.24Exp: 2014-09-15→ Common stock (250,000 underlying)
  • Award

    Stock option (right to buy)

    2005-12-08+500,000→ 500,000 total
    Exercise: $0.80Exp: 2015-01-20→ Common stock (500,000 underlying)
  • Award

    Stock option (right to buy)

    2005-12-08+250,000→ 250,000 total
    Exercise: $0.80Exp: 2014-09-15→ Common stock (250,000 underlying)
  • Disposition to Issuer

    Stock option (right to buy)

    2005-12-08−500,000→ 0 total
    Exercise: $0.24Exp: 2015-01-20→ Common stock (500,000 underlying)
Footnotes (4)
  • [F1]The options vest and become exercisable as to 30% of the options on September 15, 2005; another 30% of the options on September 15, 2006; and the remaining 40% of the options on September 15, 2007.
  • [F2]The transaction involved an amendment of outstanding options to change the exercise price with respect to 250,000 options from $0.24 to $0.80, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options.
  • [F3]The options vest and become exercisable as to 30% of the options on January 20, 2006; another 30% of the options on January 20, 2007; and the remaining 40% of the options on January 20, 2008.
  • [F4]The transaction involved an amendment of outstanding options to change the exercise price with respect to 500,000 options from $0.24 to $0.80, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001228627

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 9:05 PM ET
Size
12.7 KB
View on SEC.gov